Cover Image
市場調查報告書

Bellicum Pharmaceuticals, Inc.:產品平台分析

Bellicum Pharmaceuticals, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 224752
出版日期 內容資訊 英文 34 Pages
訂單完成後即時交付
價格
Back to Top
Bellicum Pharmaceuticals, Inc.:產品平台分析 Bellicum Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日期: 2015年09月09日 內容資訊: 英文 34 Pages
簡介

Bellicum Pharmaceuticals, Inc. 是正在開發治療癌症用劃時代細胞免疫療法的生物製藥公司。該公司正在開發藉由給藥可正確控制病情的新治療方法。

本報告提供Bellicum Pharmaceuticals, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Bellicum Pharmaceuticals, Inc.的基本資料 概要

  • 主要資訊
  • 企業資料

Bellicum Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Bellicum Pharmaceuticals, Inc.:評估

  • 各開發階段的開發中產品
  • 單劑產品

Bellicum Pharmaceuticals, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Bellicum Pharmaceuticals, Inc.:藥物簡介

  • BPX-101
  • BPX-501
  • BPX-201
  • Cell Therapy for GD2 Expressing Solid Tumors
  • BPZ-2003
  • CIDeCAR

Bellicum Pharmaceuticals, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Bellicum Pharmaceuticals, Inc.:最近的開發平台趨勢

Bellicum Pharmaceuticals, Inc.:暫停中的計劃

Bellicum Pharmaceuticals, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07566CDB

Summary

Global Markets Direct's, 'Bellicum Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Bellicum Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bellicum Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Bellicum Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Bellicum Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Bellicum Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Bellicum Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Bellicum Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Bellicum Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Bellicum Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bellicum Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Bellicum Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Bellicum Pharmaceuticals, Inc. Snapshot
    • Bellicum Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Bellicum Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Bellicum Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Bellicum Pharmaceuticals, Inc. - Pipeline Products Glance
    • Bellicum Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Bellicum Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Bellicum Pharmaceuticals, Inc. - Drug Profiles
    • BPX-501
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cell Therapy for GD2 Expressing Solid Tumors
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BPX-401
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BPX-601
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BPX-701
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cell Therapy to Target Her2 for Solid Tumors
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Oligonucleotides for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Bellicum Pharmaceuticals, Inc. - Pipeline Analysis
    • Bellicum Pharmaceuticals, Inc. - Pipeline Products by Target
    • Bellicum Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Bellicum Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Bellicum Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Bellicum Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Bellicum Pharmaceuticals, Inc. - Dormant Projects
  • Bellicum Pharmaceuticals, Inc. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • BPX-201
  • Bellicum Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Bellicum Pharmaceuticals, Inc., Key Information
  • Bellicum Pharmaceuticals, Inc., Key Facts
  • Bellicum Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Bellicum Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Bellicum Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Bellicum Pharmaceuticals, Inc. - Phase I, 2015
  • Bellicum Pharmaceuticals, Inc. - Preclinical, 2015
  • Bellicum Pharmaceuticals, Inc. - Discovery, 2015
  • Bellicum Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Bellicum Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
  • Bellicum Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Bellicum Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Bellicum Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Bellicum Pharmaceuticals, Inc. - Dormant Developmental Projects,2015
  • Bellicum Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2015

List of Figures

  • Bellicum Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
  • Bellicum Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Bellicum Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Bellicum Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
  • Bellicum Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Bellicum Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top